Medscape
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD). The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio, from Fujirebio Diagnostics, Inc., is for the early detection of amyloid plaques associated with AD in adults aged 55 years and older who show signs …
Read More
FDA Clears First Diagnostic Blood Test for AD
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD). The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio, from Fujirebio Diagnostics, Inc., is for the early detection of amyloid plaques associated with AD in adults aged 55 years and older who show signs